Markets

Health Care Sector Update for 01/24/2017: CLRB

Top Health-care stocks:

JNJ: -1.8%

PFE: +0.3%

ABT: flat

MRK: +0.6%

AMGN: flat

Health-care shares were mixed in pre-market trade on Tuesday.

In health-care stocks news, Cellectar Biosciences ( CLRB ), an oncology-focused biotechnology company, has been granted a U.S. patent covering the method of use for its lead compound, CLR 131, as well as CLR 125, to treat cancer.

Shares in the company were 15.2% higher at $1.59 pre-bell. The stock has traded between $1 and $7.40 over the past 52 weeks.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

CLRB

Other Topics

US Markets

Latest Markets Videos

    MTNewswires

    Founded in 1999, MT Newswires (formerly known as Midnight Trader) is a leading provider of original source, multi-asset class, real-time, global financial news and information to most of the largest banks, brokerage firms and professional market data, trading & research applications in North America.

    Learn More